Constance Albarracin, M.D., Ph.D.

Pathologist, MD Anderson Cancer Center

Jairam Krishnamurthy, M.D., F.A.C.P.

Medical Oncologist, Univ. of Nebraska Medical Center

Accredited by

American Society of Clinical Oncology

Course Description

Learning Objectives:
- In localized and metastatic, untreated triple-negative breast cancer, evaluate the impact of PD-L1 test results on treatment options
- Assess the role of genetic testing for patients diagnosed with untreated triple-negative breast cancer and how results guide treatment decisions
- Apply the principles of chemotherapy in localized and advanced-stage triple-negative breast cancer

Activity Details

Credit Types:CME / MOC / CE
Credit Amount:0.50 Credits
Release Date:2020-Sep-22
Expiration Date:2021-Sep-22
Estimated Time for Completion:30 minutes
Registration Required:Yes

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.